News
WHO Approves First Long-Acting Device to Shield Women From HIV
03 December 2021
World AIDS Day: Are long-acting HIV therapies the future?
01 December 2021
Europe gives green light to first long-acting injectable treatment for schizophrenia in adults
26 November 2021
NIH Grant Boosts Delpor’s Plans for Tizanidine Implant
21 November 2021
Long-Acting Antibody Combo Reduced Risk of Symptomatic COVID-19 in Phase 3 Trials
20 November 2021
'Great step forward’ for HIV treatment as long-acting jabs to replace daily pills
19 November 2021
AstraZeneca files for Health Canada approval of new COVID-19 therapy
12 November 2021
VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease
26 October 2021
Trials for clinical injectable ARVs start in Uganda
25 October 2021
NIH Statement on World AIDS Day 2021
03 December 2021
NIH Statement on World AIDS Day 2021
03 December 2021
WHO Approves First Long-Acting Device to Shield Women From HIV
03 December 2021
World AIDS Day: Are long-acting HIV therapies the future?
01 December 2021
Europe gives green light to first long-acting injectable treatment for schizophrenia in adults
26 November 2021
NIH Grant Boosts Delpor’s Plans for Tizanidine Implant
21 November 2021
Long-Acting Antibody Combo Reduced Risk of Symptomatic COVID-19 in Phase 3 Trials
20 November 2021